what they said (Hover the mouse cursor over underlined words for more info)

Tests of the first two oral drugs developed for treating multiple sclerosis (MS) show that both cut the frequency of relapses and may slow progression of the disease, but with side effects that could pose a tough decision for patients.

The original article can be found at: http://news.ninemsn.com.au/health/1002302/ms-pills-show-promise-and-risk-studies

how did it rate? (more information)

what we said (Hover the mouse cursor over underlined words for more info)

This is a detailed and balanced story that accurately reflects the information contained in three trial reports about new treatments for multiple sclerosis. Particular strengths are the details of the trial methods, the extensive coverage of adverse effects, the balance between benefit and harm, the mention of trial sponsorship and the independence of the informants cited by the journalist.

public forum

voice your opinion in the forum

• All comments and feedback submitted to Media Doctor are subject to editorial approval before being made viewable by the public. It may take up to a week for your comments to be approved. Additionally, no response will be given to questions posed in public comments. Media Doctor does not provide medical advice, or answers to medical questions posed by the public.
• If you provide your email address it will not be displayed to the general public.
• Comments may be edited by Media Doctor to remove defamatory or sensitive statements, and brand names.
• Required fields are marked with an asterisk (*).